Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports.
Conclusion: Our preliminary uncontrolled case reports suggest that HBO2 therapy may promptly improve the progressive hypoxemia of patients with COVID-2019 pneumonia. However, the limited sample size and study design preclude a definitive statement about the potential effectiveness of HBO2 therapy to COVID-2019 pneumonia. It requires evaluation in randomized clinical trials in future.
PMID: 32574433 [PubMed - in process]
Source: Undersea and Hyperbaric Medicine - Category: Sports Medicine Authors: Guo D, Pan S, Wang M, Guo Y Tags: Undersea Hyperb Med Source Type: research
More News: Clinical Trials | COVID-19 | Hyperbaric Oxygen Therapy | Liver | Pneumonia | Pneumothorax | Respiratory Medicine | Sports Medicine | Study | Urology & Nephrology